The Drug Discovery Services Market is expected to exceed more than US$ 14.5 Billion by 2024 at a CAGR of 11% in the given forecast period.
The major factors driving the expansion of this market are increasing analysis and development expenditure, inclination of major pharmaceutical companies towards outsourcing to avoid hurdles and increasing demand for outsourcing of analytical testing and clinical test services. However, the high value concerned in drug discovery and development, demanding regulations governing drug discovery, and animal usage are restraining the expansion of this market.
Browse Full Report: https://www.marketresearchengine.com/drug-discovery-services-market
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report Thermo Fisher Scientific, Merck, Healthcare, Albany Molecular Research, Inc, Charles River Laboratories International, Evotec, Pharmaceutical Product Development, LLC, Jubilant Biosys, Covance, Genscript Biotech Corporation, Aurigene Discovery Technologies and Wuxi Apptec. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The scope of the report includes a detailed study of Drug Discovery Services Market with the reasons given for variations in the growth of the industry in certain regions.
This report provides:
1) An overview of the global market for Drug Discovery Services Marketand related technologies.
2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2024.
3) Identifications of new market opportunities and targeted promotional plans for Drug Discovery Services Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
The Drug Discovery Services Market has been segmented as below:
The Drug Discovery Services Market is Segmented on the lines of Type, Drug Type, Therapeutic Area and Regional Analysis. By Type this market is segmented on the basis ofMedicinal Chemistry, Biology Services and Drug Metabolism and Pharmacokinetics (DMPK). By Drug Type this market is segmented on the basis ofSmall Molecules and Biologics.
By Therapeutic Area this market is segmented on the basis ofOncology, Neurology, Cardiovascular Diseases, Respiratory Diseases, Diabetes and Other Therapeutic Areas. By Regional Analysis this market is segmented on the basis ofNorth America, Europe, Asia-Pacific and Rest of the World.
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Drug Discovery Services Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Drug Discovery Services Market.
4) Assess your competitor’s refining portfolio and its evolution.
The major driving factors of Drug Discovery Services Market are as follows:Increasing R&D Expenditure Initiatives for Research on Rare Diseases
The major restraints factors of Drug Discovery Services Market are as follows:High Cost of Drug Discovery and Development
Request sample Report from here:https://www.marketresearchengine.com/drug-discovery-services-market
Table of ContentsIntroduction Research Methodology Summary with Insights Market Overview
4.4 Industry Trends
4.5 Porter’s Five Forces Analysis
10.4 Thermo Fisher Scientific
10.5 Aurigene Discovery Technologies
10.6 Charles River Laboratories International
10.7 Wuxi Apptec
10.8 Pharmaceutical Product Development, LLC.
10.9 Jubilant Biosys
10.10 Albany Molecular Research, Inc.
10.12 Genscript Biotech Corporation
Other Related Market News :
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States